학술논문
A 3-week nonalcoholic steatohepatitis mouse model allows the rapid evaluation of liraglutide and elafibranor benefits on NASH
Document Type
Abstract
Author
Source
In Metabolism March 2020 104 Supplement
Subject
Language
ISSN
0026-0495